(MENAFN) A groundbreaking study published in the British scientific journal Nature has provided a promising breakthrough in anti-ageing. Researchers from the Duke-NUS School of Medicine in Singapore and Imperial College London have found that blocking a protein called interleukin-11 (IL-11) could significantly extend lifespan and prevent age-related health problems. The study, conducted in mice, revealed that elevated levels of IL-11, which increase with age, contribute to a range of age-related symptoms, including fat accumulation, muscle loss, hair loss and cancer.
In this experiment, middle-aged mice were given a drug designed to block IL-11 using an antibody. The results were astonishing: the lifespan of both male and female mice increased by up to 25 percent. Treated mice also showed improved overall health and vitality compared to mice that did not receive the treatment. What’s more, fewer than 16 percent of treated mice developed tumors, a significant reduction compared to more than 60 percent in the control group.
Although the study was conducted in mice, scientists are optimistic about the potential impact on human health. Anissa A. Wijaya from Duke-NUS School of Medicine said she hopes the findings will also apply to humans, given that similar effects have been observed in studies on human cells and tissues. Stuart Cook, professor of cardiovascular medicine, stressed that the goal is to make anti-IL-11 therapy widely available in the future to help people around the world live longer, healthier lives.
MENAFN21072024000045015687ID1108463790
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, please contact the provider above.
